MA38948B1 - Dérivés de 2h-indazole antibactériens - Google Patents

Dérivés de 2h-indazole antibactériens

Info

Publication number
MA38948B1
MA38948B1 MA38948A MA38948A MA38948B1 MA 38948 B1 MA38948 B1 MA 38948B1 MA 38948 A MA38948 A MA 38948A MA 38948 A MA38948 A MA 38948A MA 38948 B1 MA38948 B1 MA 38948B1
Authority
MA
Morocco
Prior art keywords
antibacterial
indazole derivatives
halogen
indazole
derivatives
Prior art date
Application number
MA38948A
Other languages
English (en)
Other versions
MA38948A1 (fr
Inventor
Jean-Philippe Surivet
Jean-Christophe Gauvin
Azely Mirre
Etienne Ochala
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of MA38948A1 publication Critical patent/MA38948A1/fr
Publication of MA38948B1 publication Critical patent/MA38948B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/65031—Five-membered rings having the nitrogen atoms in the positions 1 and 2
    • C07F9/65038—Five-membered rings having the nitrogen atoms in the positions 1 and 2 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epidemiology (AREA)

Abstract

La présente invention concerne des composés antibactériens de formule (i) dans laquelle r1 est h ou halogène; r2 est alkynyloxy ou le groupe m; r3 est h ou halogène; m est un parmi les groupes (a, b, c, d) dans lequel a est une liaison, ch2 ch2, ch=ch ou c=c et r1a, r2a, r3a, r1b et r1c sont tels que définis dans la revendication 1; et des sels de ceux-ci.
MA38948A 2013-09-13 2014-09-12 Dérivés de 2h-indazole antibactériens MA38948B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013058537 2013-09-13
PCT/IB2014/064458 WO2015036964A1 (fr) 2013-09-13 2014-09-12 Dérivés de 2h-indazole antibactériens

Publications (2)

Publication Number Publication Date
MA38948A1 MA38948A1 (fr) 2017-05-31
MA38948B1 true MA38948B1 (fr) 2018-04-30

Family

ID=51688371

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38948A MA38948B1 (fr) 2013-09-13 2014-09-12 Dérivés de 2h-indazole antibactériens

Country Status (29)

Country Link
US (1) US9802901B2 (fr)
EP (1) EP3044211B1 (fr)
JP (1) JP6353909B2 (fr)
KR (1) KR20160055889A (fr)
CN (1) CN105531264B (fr)
AR (1) AR097617A1 (fr)
AU (1) AU2014319966B2 (fr)
BR (1) BR112016007757A8 (fr)
CA (1) CA2923146A1 (fr)
CL (1) CL2016000568A1 (fr)
CY (1) CY1120111T1 (fr)
DK (1) DK3044211T3 (fr)
EA (1) EA031562B1 (fr)
ES (1) ES2662894T3 (fr)
HR (1) HRP20180484T1 (fr)
HU (1) HUE038519T2 (fr)
IL (1) IL244500B (fr)
LT (1) LT3044211T (fr)
MA (1) MA38948B1 (fr)
MX (1) MX361733B (fr)
MY (1) MY179283A (fr)
PH (1) PH12016500480A1 (fr)
PL (1) PL3044211T3 (fr)
PT (1) PT3044211T (fr)
SG (1) SG11201601889YA (fr)
SI (1) SI3044211T1 (fr)
TW (1) TWI646084B (fr)
UA (1) UA116484C2 (fr)
WO (1) WO2015036964A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160098503A (ko) 2013-12-19 2016-08-18 액테리온 파마슈티칼 리미티드 항균성 1h-인다졸 및 1h-인돌 유도체
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015173329A1 (fr) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Dérivés antibactériens de quinazoline-4(3h)-one
BR112017010474A2 (pt) 2014-11-19 2017-12-26 Actelion Pharmaceuticals Ltd derivados antibacterianos de benzotiazol
AR105646A1 (es) * 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
AR105839A1 (es) * 2015-08-28 2017-11-15 Actelion Pharmaceuticals Ltd Derivados antibacterianos pirrolidin-2-ona anulares
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
AU2017267194A1 (en) * 2016-05-17 2019-01-17 Idorsia Pharmaceuticals Ltd 6-(BUTA-1,3-DIYN-1-YL)benzo[D]thiazole derivatives
WO2019038362A1 (fr) 2017-08-24 2019-02-28 Idorsia Pharmaceuticals Ltd Pyrroloimidazolones antibactériennes
CN113372276B (zh) * 2021-05-25 2022-04-22 三峡大学 吲唑类衍生物及其应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2469304A1 (fr) 2001-12-05 2003-06-19 Ortho-Mcneil Pharmaceutical, Inc. Agents anti-bacteriens de 6-o-acyl cetolide
US6806279B2 (en) 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
SG2013013339A (en) 2002-03-13 2014-12-30 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
EP1828145A4 (fr) 2004-12-10 2009-08-19 Univ Emory Analogues de nucleosides de cyclobutyle a substitution 2' et 3' pour le traitement des infections virales et de la proliferation cellulaire anormale
PT1863818E (pt) 2005-03-23 2010-04-09 Hoffmann La Roche Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
CA2691987C (fr) 2007-06-12 2016-08-16 Achaogen, Inc. Agents antibacteriens
DE102008044132A1 (de) 2008-11-27 2010-06-02 BSH Bosch und Siemens Hausgeräte GmbH Kältegerät mit zweiseitig anschlagbarer Tür
WO2010100475A1 (fr) 2009-03-02 2010-09-10 Astrazeneca Ab Dérivés de l'acide hydroxamique en tant qu'agents contre des bactéries à gram négatif
WO2010135536A2 (fr) 2009-05-20 2010-11-25 Ardea Biosciences, Inc. Procédés pour moduler des taux d'acide urique
CN102548975A (zh) 2009-07-07 2012-07-04 安瑟生物科技私人有限公司 组蛋白去乙酰化酶抑制剂
CA2774250C (fr) * 2009-10-13 2013-12-17 Pfizer Inc. Derives d'acide hydroxamique a liaison c utiles comme agents antibacteriens
JP5793766B2 (ja) 2009-12-16 2015-10-14 ファイザー・インク 抗菌剤として有用なn−結合型ヒドロキサム酸誘導体
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
EP2638006A1 (fr) 2010-11-10 2013-09-18 Achaogen, Inc. Dérivés d'acide hydroxamique et leur utilisation dans le traitement d'infections bactériennes
KR20120079015A (ko) 2011-01-03 2012-07-11 한미약품 주식회사 G 단백질-커플링된 수용체의 조절을 위한 신규한 비사이클릭 화합물
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
WO2012137094A1 (fr) 2011-04-08 2012-10-11 Pfizer Inc. Dérivés d'isoxazole utiles en tant qu'agents antibactériens
WO2012137099A1 (fr) * 2011-04-08 2012-10-11 Pfizer Inc. Dérivés d'imidazole, de pyrazole et de triazole, utiles en tant qu'agents antibactériens
EP2847162A1 (fr) 2012-05-09 2015-03-18 Achaogen, Inc. Agents antibactériens
KR20160098503A (ko) 2013-12-19 2016-08-18 액테리온 파마슈티칼 리미티드 항균성 1h-인다졸 및 1h-인돌 유도체
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015173329A1 (fr) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Dérivés antibactériens de quinazoline-4(3h)-one

Also Published As

Publication number Publication date
UA116484C2 (uk) 2018-03-26
EP3044211B1 (fr) 2018-01-03
MX2016003196A (es) 2016-06-02
LT3044211T (lt) 2018-04-10
US9802901B2 (en) 2017-10-31
SG11201601889YA (en) 2016-04-28
MY179283A (en) 2020-11-03
PT3044211T (pt) 2018-03-21
IL244500A0 (en) 2016-04-21
SI3044211T1 (en) 2018-04-30
WO2015036964A1 (fr) 2015-03-19
PH12016500480B1 (en) 2016-05-16
JP2016530327A (ja) 2016-09-29
EA201600248A1 (ru) 2016-08-31
BR112016007757A8 (pt) 2018-08-14
CY1120111T1 (el) 2018-12-12
MA38948A1 (fr) 2017-05-31
HRP20180484T1 (hr) 2018-05-04
CL2016000568A1 (es) 2016-11-11
AU2014319966B2 (en) 2018-11-15
JP6353909B2 (ja) 2018-07-04
TW201542531A (zh) 2015-11-16
ES2662894T3 (es) 2018-04-10
CN105531264B (zh) 2018-04-10
TWI646084B (zh) 2019-01-01
MX361733B (es) 2018-12-14
CA2923146A1 (fr) 2015-03-19
AR097617A1 (es) 2016-04-06
US20160221959A1 (en) 2016-08-04
BR112016007757A2 (pt) 2018-07-10
PL3044211T3 (pl) 2018-06-29
AU2014319966A1 (en) 2016-05-05
CN105531264A (zh) 2016-04-27
KR20160055889A (ko) 2016-05-18
EP3044211A1 (fr) 2016-07-20
EA031562B1 (ru) 2019-01-31
IL244500B (en) 2018-05-31
HUE038519T2 (hu) 2018-10-29
DK3044211T3 (en) 2018-03-12
PH12016500480A1 (en) 2016-05-16

Similar Documents

Publication Publication Date Title
MA38948A1 (fr) Dérivés de 2h-indazole antibactériens
CY1121549T1 (el) Ενωσεις 1-αρυλκαρβονυλ-4-oξυ-πιπεριδινης χρησιμες για την αγωγη νευροεκφυλιστικων παθησεων
WO2019035863A8 (fr) Activateurs de la pyruvate kinase destinés à être utilisés dans le traitement de troubles hématologiques
BRPI1009637A2 (pt) composto, composição e uso de um composto
MA37940A2 (fr) Nouveaux dérivés bicycliques
EA201690019A1 (ru) Производное аминотриазина и содержащая его фармацевтическая композиция
EA200970510A1 (ru) Гетеромоноциклическое соединение и его применение
EA201690153A1 (ru) Замещенные бензофуранильные и бензоксазолильные соединения и их применения
MA37756A1 (fr) Nouveaux composés diazaspirocycloalcane et azaspirocycloalcane
CY1113989T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
CO6300954A2 (es) Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk
MA35434B1 (fr) Amino-quinazolines en tant qu'inhibiteurs de kinase
CY1120477T1 (el) Ενεργοποιητης του υποδοχεα που ενεργοποιειται απο πολλαπλασιαστες των υπεροξεισωματων
AR072016A1 (es) Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato
MA39152A1 (fr) Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine
PE20141553A1 (es) Compuestos de triazolopiridina como inhibidores de la ped10a
PH12016501699A1 (en) 1,2-dihydro-3h-pyrrolo[1,2-c]imidazol-3-one derivatives and their use as antibacterial agents
TN2015000490A1 (fr) Dérivés d'imidazo-triazine servant d' inhibiteurs de pde10
MA39315A1 (fr) Dérivés de pyridazine à utiliser dans la prévention ou le traitement d'un trouble ataxique
NZ746906A (en) Oxaborole esters and uses thereof
MA37719A1 (fr) Dérivés de pyrimidinone en tant qu'agents anti-malaria
MX374758B (es) Inhibidores de tirosina cinasa de bruton.
MX370010B (es) Inhibidores de tirosina cinasa de bruton.
MA39305A3 (fr) Dérivés d'éthynyle